One Cream, Growing List: How Topical JAK Inhibitors Keep Collecting Indications
Two are now approved, the indications keep expanding, and both carry a boxed warning inherited from a pill that behaves nothing like a cream.
Tretinoin, hydroquinone, spironolactone, isotretinoin.
Two are now approved, the indications keep expanding, and both carry a boxed warning inherited from a pill that behaves nothing like a cream.
Four fields on a prescription label decide whether a treatment can possibly work — strength, vehicle, quantity and refills — and patients are almost never walked through any of them.
Bespoke medicine, or four familiar actives in one jar with your name printed on it? Compounding is genuinely useful and genuinely unreviewed, and the difference matters most in the places nobody advertises.
The FDA approved the biggest reduction in isotretinoin paperwork in years, then moved the start date twice. Here is what actually changes, what does not, and the date that now matters.
Guidelines cap oral antibiotics for acne at around three months. One chart review found the average patient who eventually needed isotretinoin had been on them for 331 days.
Clear skin arrives months before the course is finished, which makes the mirror the least reliable instrument in the room — and the most persuasive.
It gets discussed as either a miracle or a hazard. It is neither — it is a defined course with a predictable arc, and knowing the shape of it is what gets people through month two.
The same corticosteroid molecule is meaningfully stronger in an ointment than in a cream — and the base it arrives in decides whether the prescription irritates you, and whether you finish the course at all.
Topical tranexamic acid went mainstream in your serums. The quieter, more powerful version is a low-dose pill — and it comes with a clotting conversation attached.
One quietly brilliant ingredient treats acne, rosacea, and dark spots — and you can buy it two ways. Whether the stronger version earns the appointment depends entirely on what you're treating.